Clinical Trial Detail

NCT ID NCT01720836
Title Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Olivera Finn
Indications

lung non-small cell carcinoma

Therapies

MUC1 peptide-Poly-ICLC vaccine

Age Groups: senior adult

No variant requirements are available.